Monarch Partners Asset Management’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.83M Sell
46,172
-44,752
-49% -$1.86M 0.54% 93
2022
Q3
$4.2M Buy
90,924
+54,512
+150% +$2.67M 1.26% 13
2022
Q2
$1.57M Hold
36,412
0.44% 112
2022
Q1
$1.97M Hold
36,412
0.44% 106
2021
Q4
$2.18M Buy
36,412
+3,082
+9% +$192K 0.44% 111
2021
Q3
$2.18M Buy
33,330
+5,825
+21% +$378K 0.32% 109
2021
Q2
$1.74M Buy
27,505
+5,340
+24% +$307K 0.25% 122
2021
Q1
$1.08M Sell
22,165
-650
-3% -$31.2K 0.16% 129
2020
Q4
$941K Buy
22,815
+5,045
+28% +$231K 0.16% 141
2020
Q3
$816K Buy
+17,770
New +$824K 0.18% 130
2018
Q3
Sell
-18,430
Closed -$491K 199
2018
Q2
$491K Sell
18,430
-12,500
-40% -$267K 0.04% 178
2018
Q1
$466K Buy
30,930
+13,240
+75% +$234K 0.04% 176
2017
Q4
$339K Buy
+17,690
New +$338K 0.03% 173

Other funds holding KIDS

Monarch Partners Asset Management's KIDS Position: Q4 2022 in Review

Monarch Partners Asset Management reduced its OrthoPediatrics (KIDS) stake by 49% in Q4 2022, selling an estimated $1.86M and leaving 46,172 shares worth $1.83M. The position accounts for 0.54% of the portfolio, ranked #93.

Monarch Partners Asset Management first reported a position in KIDS in Q4 2017 and has held it in 13 quarters since. The position peaked at $4.2M in Q3 2022. 118 funds tracked by Wall St. Rank hold KIDS as of Q4 2022.

  • Monarch Partners Asset Management held 46,172 shares of OrthoPediatrics worth $1.83M as of Q4 2022.
  • Monarch Partners Asset Management sold 44,752 OrthoPediatrics shares in Q4 2022, an estimated $1.86M.
  • OrthoPediatrics made up 0.54% of Monarch Partners Asset Management's portfolio in Q4 2022, its #93 holding.
  • Monarch Partners Asset Management first reported a position in OrthoPediatrics in Q4 2017 and has held it in 13 quarters since.
  • Monarch Partners Asset Management's OrthoPediatrics position peaked at $4.2M in Q3 2022.
  • 118 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2022.

Based on Monarch Partners Asset Management's 13F filing for Q4 2022, filed 2 Feb 2023.